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Laparoscopy/Robotics
Initial Experiences with Robot-Assisted Laparoscopic Radical 
Cystectomy
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Department of Urology, School of Medicine, Kyungpook National University, Daegu, Korea
Purpose: Robot-assisted laparoscopic radical cystectomy (RLRC) is a new option for the 
treatment of muscle-invasive bladder cancer, and case series for RLRC have been in-
creasing recently. We report our operative technique and initial experiences with RLRC 
with extracorporeal urinary diversion.
Materials and Methods: Between October 2008 and November 2009, 17 consecutive 
patients with muscle-invasive bladder cancer underwent RLRC, pelvic lymph node dis-
section, and extracorporeal urinary diversion. Urinary diversion included 13 ileal con-
duits and 4 orthotopic neobladders (Studer method). Data were collected prospectively 
on patient demographics, intraoperative parameters, pathologic staging, and post-
operative outcomes.
Results: The mean patient age was 63.7 years. The mean body mass index was 22.6 
kg/m
2. No patients had a history of previous abdominal surgery. The mean operative 
time was 379.1 minutes, including 32.6 minutes for pelvic lymph node dissection, 185.2 
minutes for RLRC, and 159.4 minutes for urinary diversion. The mean estimated blood 
loss was 210.5 ml. The mean hospital stay was 20.7 days and the mean time to oral intake 
and ambulation was 5.0 and 1.3 days, respectively. There were no major perioperative 
complications. The pathologic reports showed urothelial cell carcinomas in all cases.
Conclusions: Our initial clinical experiences indicate that RLRC with pelvic lymph node 
dissection and extracorporeal urinary diversion is a safe and feasible procedure with 
minimal blood loss and rapid recovery. Long-term follow up in a larger patient pop-
ulation is needed to determine the true oncological and functional benefit of this 
procedure.
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INTRODUCTION
Open radical cystectomy (ORC) is currently regarded as 
the gold standard for the management of muscle-invasive 
bladder cancer, extensive uncontrollable non-muscle-in-
vasive cancer, and refractory carcinoma in situ (CIS) [1,2]. 
Although recent development and refinement of surgical 
technique has improved postoperative patients’ quality of 
life and has reduced complications, ORC is still associated 
with significant morbidity. Therefore, urologists have at-
tempted various techniques to reduce the morbidity. 
Laparoscopic radical cystectomy (LRC) is one of the mini-
mally invasive options, and some reports have shown that 
oncological outcomes were equivalent to ORC [3-5].
　However, LRC does not yet have widespread use because 
of the technical difficulty of the procedure and long oper-
ation time. With the recent development of the da Vinci
Ⓡ 
robot system, robot-associated laparoscopic surgery has 
been applied to radical cystectomy. Surgeons have begun 
to report small series of robot-assisted laparoscopic radical 
cystectomy (RLRC) [6-8]. These reports have demon-
strated the surgical effectiveness of RLRC with advan-
tages in blood loss, return of bowel function, and even hospi-
tal discharge [9,10]. However, a large case of prospective 
randomized trials has not been reported. In this study, we 
present the short-term clinical and oncologic outcomes of 
our 17 consecutive cases of RLRC with pelvic lymph node 
dissection and extracorporeal urinary diversion.Korean J Urol 2010;51:178-182
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TABLE 1. Baseline characteristics of the patients
Total patients
Age (years)
Sex (male/female)
Body mass index (kg/m
2)
Clinical stage
　T1 & CIS (%)
　T2 (%)
　≥T3 (%)
ASA score
63.7
12/5
22.6
3 (18)
1 (5)
13 (76)
1.4
CIS: carcinoma in situ, ASA: American Society of Anesthesiolo-
gists
FIG. 1. Port placement of robot-assisted laparoscopic radical 
cystectomy.
FIG. 2. Postoperative surgical wound of robot-assisted laparo-
scopic radical cystectomy with ileal conduit (A) and orthotopic 
neobladder (B).
MATERIALS AND METHODS
Between October 2008 and November 2009, a total of 17 
consecutive patients underwent RLRC using the da Vinci
Ⓡ 
robot system (Intuitive Surgical, Sunnyvale, USA) with 
four robot arms by a single surgeon. The patients included 
5 women and 12 men with a mean age of 63.7 years (range, 
48-74 years). According to American Society of Anesthesi-
ologists (ASA) risk classification, 10 were ASA score I and 
7 were ASA score II. Mean body mass index (BMI) was 22.6 
kg/m
2 (range, 18.3-26.5 kg/m
2) (Table 1).
　All patients requiring cystectomy were offered the ro-
bot-assisted operation if they met the inclusion criteria. 
These consisted of patients with radiologically localized 
disease, no history of previous major lower abdominal pel-
vic surgery, no previous pelvic radiation, and ability to tol-
erate a steep Trendelenburg position at the anesthetic 
assessment.
　All patients received mechanical bowel preparation 
(using an osmotic laxative) 2 days prior to surgery and a 
phosphate enema 8 hours prior to surgery. Intravenous an-
tibiotics were administered at the induction of general 
anesthesia. An elastic stocking was used for prophylaxis 
of deep vein thrombosis.
　Surgical techniques were as follows. Patients were 
placed in the extended lithotomy with 30
o Trendelenburg 
position. A six-port transperitoneal approach was used. 
The 12 mm camera port was inserted in the midline 5 cm 
above the upper umbilical margin and two 8 mm robotic 
ports were placed 8 cm away from the umbilicus, along the 
line from the umbilicus to the anterior spine of the iliac 
crest (ASIC) bilaterally. An additional 8 mm robotic port 
for the fourth arm was placed 8 cm directly lateral from the 
right-sided robotic port. A 12 mm assistant port for re-
traction and stapling was placed 8 cm lateral from the 
left-side robotic port. A further 5 mm assistant port for suc-
tion and irrigation was placed on the left side between the 
camera port and the left robotic arm port (Fig. 1). After 
docking of the robotic system, radical cystectomy was per-
formed by the same process as standard LRC. Standard 
pelvic lymphadenectomies (both obturator, external iliac) 
were performed in all patients.
　All patients underwent extracorporeal urinary diver-
sions (13 ileal conduits and 4 orthotopic neobladders by 
Studer method) and 5-7 cm lower midline incisions were 
made for specimen removal and urinary diversion. In case 
of an ileal conduit, uretero-ileal anastomosis was per-
formed over 6 Fr double J stents by using 4-0 PDS suture, 
and the distal end of the conduit was fashioned as a stoma 
at the right robot arm port site. All orthotopic neobladder 
was performed by using the Studer method and ureteral 
stents were used and brought out anteriorly through sepa-
rate stab wounds. Urethro-enteric anastomosis was then 
performed intracorporeally after redocking the robotic sys-
tem (Fig. 2). A Jackson-Pratt drain was placed in the pelvic 
cavity and around the uretero-enteric anastomosis site, 
respectively. The nasogastric tube was removed 4 days af-
ter surgery and oral liquids were started as tolerated. The 
drain and ureteral stents were removed at 2-3 weeks after 
surgery.
　Patients were reviewed at 4 weeks and checked by a renal Korean J Urol 2010;51:178-182
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TABLE 2. Comparison of perioperative surgical outcomes between 
the ileal conduit group the orthotopic neobladder group
IC ON p-value
Mean operative time
Urinary diversion time
Estimate blood loss (ml)
Time to oral intake (days)
Time to ambulation (days)
Postoperative hospital stay (days)
Complication (%)
a
　Acute renal failure
　Acute pyelonephritis
　Ileus
　Urine leakage
371.0
137.1
215.3
5.1
1.4
18.2
2 (15)
1
0
1
0
442.5
232.5
195.0
4.5
1.0
27.5
2 (50)
0
1
0
1
0.010
0.002
0.871
0.477
0.296
0.245
−
−
−
−
−
IC: ileal conduit, ON: orthotopic neobladder, 
a: all complication 
was successfully managed conservatively
TABLE 3. Comparison of perioperative surgical outcomes between 
male and female patients
Male Female p-value
Mean operative time
Estimate blood loss (ml)
Time to oral intake (days)
Time to ambulation (days)
Postoperative hospital stay (days)
387.0
210.8
5.0
1.25
20.1
360.0
210.0
5.0
1.6
22.2
0.383
0.552
0.524
0.241
0.428
FIG. 3. Detailed operative time of each patient. ON: orthotopic 
neobladder, IC: ileal conduit, PLND: pelvic lymph node dissec-
tion, RLRC: robot-assisted laparoscopic radical cystectomy.
ultrasound at 2 weeks after stent removal, by computed to-
mography scans at 3 and 6 months postoperatively, and 
then at 6-month intervals. At these visits, they had a clin-
ical examination, assessment of hemoglobin, electrolytes, 
creatinine, chloride, bicarbonate, and urethral washing 
cytology.
RESULTS
The mean total operative time was 379.1 minutes (range, 
330-460 minutes), including 32.6 minutes for pelvic lymph 
node dissection, 185.2 minutes for RLRC, and 159.4 mi-
nutes for urinary diversion. All patients underwent ex-
tracorporeal urinary diversions (13 ileal conduits and 4 or-
thotopic neobladders by the Studer method), and there 
were no patients who underwent urethrectomy. The mean 
operative time for the ileal conduit (IC) group was sig-
nificantly shorter than that for the orthotopic neobladder 
(ON) group (371.0 minutes vs. 442.5 minutes, p=0.010). 
The detailed operative time of each patient is shown in Fig. 
3. No intraoperative complications occurred.
　The mean estimated blood loss was 215.3 ml (range, 
120-400 ml) for the IC group and 195.0 ml (range, 180-200 
ml) for the ON group (p=0.871). The overall perioperative 
transfusion rate for RLRC was 35.2% (6/17). The time to 
oral intake and time to ambulation were 5.0 days (range, 
4-8 days) and 1.3 days (range, 1-3 days), respectively. Mean 
hospital stay was 20.7 days (range, 11-41 days), including 
18.2 days (range, 11-41 days) for the IC group and 27.5 days 
(range, 17-40 days) for the ON group (p=0.245). The time 
to oral intake (5.1 vs. 4.5 days) and time to ambulation (1.4 
vs. 1.0 day) were similar between the groups (p＞0.05). Pe-
rioperative complications occurred in 4 patients (23.5%), 
including 1 ileus, 1 acute renal failure, 1 acute pyeloneph-
ritis, and 1 urinary leakage. Every complication was suc-
cessfully managed conservatively (Table 2). There were no 
significant differences in perioperative outcomes between 
the male and female groups (Table 3).
　The pathologic reports showed urothelial cell carcinomas 
in all cases, and the pathologic stages were 1 TisN0M0, 5 
T1N0M0, 1 T1N1M0, 3 T2N0M0, 5 T3N0M0, and 2 
T4N0M0. The average number of retrieved lymph nodes 
was 5.9 (range, 0-18). One patient had lymph node meta-
stasis and 1 of 3 nodes was involved by the tumor. This pa-
tient received 3 cycles of adjuvant gemcitabine/cisplatin 
chemotherapy. No patient had a positive surgical resection 
margin. The mean follow-up period for RLRC was 8.3 
months (range, 3-19 months), and there was no local re-
currence or distant metastasis during the follow-up period. 
DISCUSSION
RLRC is in evolution and is a procedure that can combine 
the minimally invasive advantages of LRC with the techni-
cal advantages of robotics. Apart from superior visual-
ization and articulated instrumentation, the improved er-
gonomic position offered at the robotic console benefits the 
surgeon during prolonged procedures [11]. In 2003, Menon 
et al first reported the feasibility of RLRC using the da 
Vinci
Ⓡ surgical system [10]. The operative time ranged 
from 260 to 308 minutes depending on whether an ileal con-
duit or orthotopic neobladder was performed. Blood loss 
was less than 150 ml and surgical margins were clear in 
all cases. Guru et al reported their experience with RLRC 
and extracorporeal urinary diversion in 20 patients [9]. 
The mean total operative time was 442 minutes, including Korean J Urol 2010;51:178-182
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133 minutes for urinary diversion. The mean hospital stay 
was 10 days and the time to return to strenuous activity 
was 10 weeks. Rhee et al compared 23 ORC with 7 RLRC 
cases and found that although blood loss was lower for 
RLRC, 4 of 7 patients needed transfusion [12]. The oper-
ative time was 638 minutes for RLRC compared with 507 
minutes for ORC and hospital stay was 11 and 13 days, 
respectively. Pruthi and Wallen also compared 20 men un-
dergoing RLRC and extracorporeal urinary diversion with 
24 matched men who underwent ORC [13]. The mean oper-
ative time for RLRC was 6.1 hours as opposed to 3.8 hours 
for ORC. The mean blood loss was significantly less for 
RLRC. There were no positive surgical margins. A mean 
of 19 lymph nodes were removed. Mean time to flatus and 
bowel movement was significantly shorter than in men un-
dergoing ORC. There were six postoperative complications 
(30%) in five patients, including one rectal injury (repaired 
intraoperatively), one postoperative hemorrhage requir-
ing laparotomy, and one parastomal hernia requiring 
repair.
　In our initial experiences, the mean total operative time 
was 379.1 minutes (range, 330-460 minutes), including 
32.6 minutes for pelvic lymph node dissection, 185.2 mi-
nutes for RLRC, and 159.4 minutes for urinary diversion. 
These results were relative longer than that of ORC, which 
was reported in another study [1]. However, mean esti-
mated blood loss was acceptable (210.5 ml) and diet was 
usually resumed on postoperative day 4 or 5. The complica-
tion rate of our series (23.5%) was similar to other reports. 
These results might be due to lower intraoperative bleed-
ing and minimal bowel exposure and manipulation. 
Moreover, shorter surgical wounds and less postoperative 
pain can be advantages of RLRC.
　Although RLRC with complete intracorporeal urinary 
diversion has been reported [14,15], long operating times 
have prevented widespread adoption of this approach, and 
most units prefer an extracorporeal approach for urinary 
diversion [5,16]. We also performed extracorporeal urinary 
diversion in all cases to reduce operative time, but in case 
of orthotopic neobladder, urethro-ileal anastomosis was 
performed intracorporeally using a robotic system for the 
surgeon’s convenience.
　The obvious goal of RLRC must be to maintain the onco-
logic standards of ORC while reducing the associated 
morbidity. It is not clear whether pneumoperitoneum has 
an effect on the spread or recurrence of urothelial cell carci-
noma in the medium to long term. It is interesting to note 
a report of port-site metastasis following RLRC for a 
pT3bG3 urothelial cell carcinoma of the bladder [17]. It is 
hoped that this outcome will be a very rare phenomenon, 
which it appears to be with other types of laparoscopic sur-
gery [18].
　Although several studies have reported encouraging 
short-term oncologic outcomes of RLRC and our perioper-
ative outcomes of RLRC were comparable to ORC, the ulti-
mate oncologic safety of RLRC is not yet clear. To ad-
equately evaluate and validate this procedure, a random-
ized prospective trial is needed to compare ORC, LRC, and 
RLRC in terms of operative, oncological, and functional 
outcomes. Moreover, the feasibility of performing RLRC 
cannot be separated from the costs of developing new surgi-
cal methods in the current economic environment. There-
fore, the cost/benefit ratio will require continuous review.
CONCLUSIONS
Although RLRC still has concerns about long operative 
time and high cost, and long-term follow-up is needed to es-
tablish oncologic equivalence with ORC, robot-assisted 
surgery may provide benefits to patients including mini-
mal blood loss, rapid recovery, and smaller surgical 
wounds. Our initial clinical experience indicates that 
RLRC is a safe and feasible procedure that may be an alter-
native to the open technique.
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